missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Promega TNT™ Quick Coupled Transcription/Translation System 
The TNT Quick Systems are convenient single-tube, coupled transcription/translation reactions for eukaryotic cell-free protein expression.
$372.88 - $1367.67
Specifications
| Content And Storage | <-65°C |
|---|---|
| For Use With (Application) | GST pull-downs, Gel shift assays, Co-immunoprecipitation, Characterization of protein modifications, Protein-RNA interactions, Protein activity studies, Confirmation of gene products, Protein truncation test (PTT) |
| Catalog Number | Mfr. No. | Product Type | No. of Reactions | Price | Quantity | ||||
|---|---|---|---|---|---|---|---|---|---|
| Catalog Number | Mfr. No. | Product Type | No. of Reactions | Price | Quantity | ||||
|
PR-L1170
|
Promega
L1170 |
TNT T7 | 40 |
Each for $1,367.67
|
|
||||
|
PR-L1171
|
Promega
L1171 |
TNT T7 | 5 |
Each for $372.88
|
|
||||
|
PR-L2080
|
Promega
L2080 |
TNT SP6 | 40 |
Each for $1,340.00
|
|
||||
|
PR-L2081
|
Promega
L2081 |
TNT SP6 | 5 |
Each for $374.20
|
|
||||
Description
- Single-Tube, Coupled Transcription/Translation for Eukaryotic Cell-Free Protein Expression
- Functional protein is expressed in one hour, ready for use without further purification
- Use protein for protein:protein and protein:nucleic acid interactions, protein modification and more
- Choice of SP6 or T7 promoter
- U.S. Patents 5,641,641; 5,650,289; and 5,814,471; Australian Patent 649289 and other patents.
- U.S. Patents 5,324,637 and 5,492,817; Australian Patent 660329 and other patents.
- U.S. Patent 5,552,302; Australian Patent 646803 and other patents.
- The method of recombinant expression of Coleoptera luciferase is covered by U.S. Patents 5,583,024; 5,674,713; and 5,700,673. A license (from Promega for research reagent products and from The Regents of the University of California for all other fields) is needed for any commercial sale of nucleic acid contained within or derived from this product.
- Australian Patents 616881 and 641261 and other pending and issued patents, which claim vectors encoding a portion of human placental ribonuclease inhibitor, are exclusively licensed to Promega Corporation.
- For Laboratory Use. Any use of the product for diagnostics requiring clearance or approval by the FDA may require a license under Mayo Clinic U.S. Patents 6,027,913 and 6,361,949.
Specifications
| <-65°C | |
| GST pull-downs, Gel shift assays, Co-immunoprecipitation, Characterization of protein modifications, Protein-RNA interactions, Protein activity studies, Confirmation of gene products, Protein truncation test (PTT) |